Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS Study Group. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1-11. [PubMed Link]
Recent Posts
- Walk to Defeat ALS – ALS Association
- JNNP Podcast: A Roadmap to ALS Prevention – Strategies and Priorities with Dr. Michael Benatar
- The Genetics Podcast: Breakthroughs and Insights in ALS Research with Dr. Michael Benatar
- Inside U Miami Medicine Podcast: Unraveling the Mysteries of ALS with Dr. Michael Benatar
- 2024 Annual ALS Patient Symposium
Recent Comments